Partners in Health   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Boston MA United States (1987)

Organization Overview

First Clinical Trial
2007
NCT00409305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CSRA Partners in Health | CSRA Partners in Health, Inc. | Partners in Health | Partners In Health/Inshuti Mu Buzima - Rwanda

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 3)

Body Weight (Phase 2)

Communicable Diseases (Phase 3)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Gram-Positive Bacterial Infections (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Infections (Phase 3)

Mycobacterium Infections (Phase 3)

Obesity (Phase 2)

Tuberculosis (Phase 3)

Tuberculosis, Multidrug-Resistant (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 15